Abstract
The influence of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) and 1-hexadecylmercapto-2-methoxymethyl-rac-propyl-3-phosphocholine (TLP, BM41.440) on methylnitrosourea (MNU)-induced rat mammary carcinomas and of ET-18-OCH3 on 7,12-dimethylbenzanthracene (DMBA)-induced leukemias was investigated. Both agents effectively delayed MNU-induced mammary tumor formation at high, cytotoxic dosages but TLP had no influence at low “immunomodulatory” doses. ET-18-OCH3 also significantly protected against leukemia development in DMBA-treated Long-Evans rats.
Similar content being viewed by others
Abbreviations
- ET-18-OCH3 :
-
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
- TLP:
-
1-hexadecylmercapto-2-methoxymethyl-rac-propyl-3-phosphocholine
- DMBA:
-
7,12-dimethylbenzanthracene
References
Brock, N., Pohl, J., Stekar, J., and Scheef, W. (1982)Eur. J. Cancer Clin. Oncol. 18, 1377–1387.
Ormstad, K., Orrenius, S., Lastbom, T., Kehara, N., Pohl, J., Stekar, J., and Brock, N. (1983)Cancer Res. 43, 333–338.
Schmähl, D., and Habs, M. (1978)Arzneim. Forsch./Drug Res. 28, 49–51.
Schmähl, D., and Habs, M. (1981)Arzneim. Forsch./Drug Res. 31, 677–679.
Aksoy, M., Berger, M.R., and Schmähl, D. (1985)Arch. Geschwulstforsch. 55, 443–450.
Schmähl, D., Krüger, W., Habs, M., and Diehl, B. (1976)Z. Krebsforsch. 85, 271–276.
Habs, M., Schmähl, D., and Kretzer, H. (1981)Oncology 38, 18–22.
Habs, M., and Schmähl, D. (1983)Cancer 51, 606–609.
Munder, P.G., Modolell, M., Bausert, W., Oettgen, H.F., and Westphal, O., (1981) inAugmenting Agents in Cancer Therpy (Hersh, E.M., Chirigos, M.A., and Mastrangelo, M.J., eds.) pp. 441–458, Raven Press, New York.
Berdel, W.E., Andreesen, R., and Munder, P.G. (1985) inPhospholipids and Cellular Regulation (J.F. Kuo, ed.), II, pp. 41–73, CRC Press, Boca Raton, FL.
Berger, M.R., Habs, M., and Schmähl, D. (1986)Proc. Am. Assoc. Cancer Res. 27, 284.
Berger, M.R., Munder, P.G., Schmähl, D., and Westphal, O. (1984)Oncology 41, 109–113.
Zeller, W.J., Berger, M., and Schmähl, D. (1980)J. Cancer Res. Clin. Oncol. 96, 157–162.
Berger, M.R., and Schmähl, D. (1986)Cancer Lett. 30, 73–78.
Dunn, O.J. (1964)Technometrics 6, 241–252.
Peto, R., Pike, M.C., Day, N.E., Gray, R.G., Lee, P.N., Parish, S., Peto, J., Richards, S., and Wahrendorf, J. (1980) inIARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Long-term and Short-term Screening Assays for Carcinogens, a Critical Appraisal, Suppl. 2, pp. 311–426, IARC (Publ.) Lyon, France.
Munder, P.G., Modolell, M., Adreesen, R., Berdel, W., Pahlke, W., Oepke, R., and Westphal, O. (1983) in13th International Cancer Congress, Part B, Biology of Cancer (1) (Mirand, E.A., Hutchinson, W.B., and Mihich, E., eds.), pp. 393–402. Alah R. Liss Inc., New York.
Berdel, W.E., Luz, A., Rastetter, J., Fink, U., Gössner, W., and Messerschmidt, O. (1983)Cancer Lett. 20, 215–221.
King, M.T., Eckhardt, K., Gocke, E., Wild, D., Berdel, W.E., and Munder, P.G. (1981)Cancer Lett. 12, 217–222.
Author information
Authors and Affiliations
About this article
Cite this article
Berger, M.R., Schmähl, D. Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids. Lipids 22, 935–942 (1987). https://doi.org/10.1007/BF02535559
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02535559